Bleeding risk and safety profile related to the use of eptifibatide: a current review

By Saab Fadi   Ionescu Costin   J. Schweiger Marc  

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

The safety of clopidogrel

By Mangalpally Kiran Kumar R   Kleiman Neal S  

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 85-95

Informa Healthcare

Access to resources Recommend Favorite

Intracranial Bleeding Associated with Clopidogrel

By Cay Serkan   Yilmaz Mehmet   Korkmaz Sule  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 2, 2005-03 ,pp. : 157-158

Springer Publishing Company

Access to resources Recommend Favorite

Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis

By  

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 465-477

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor

By Giorgi Mariano A   Cohen Arazi Hernáán   Gonzalez Claudio D   Di Girolamo Guillermo  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1285-1295

Informa Healthcare

Access to resources Recommend Favorite